Cue Health Balance Sheet Health

Financial Health criteria checks 4/6

Cue Health has a total shareholder equity of $250.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $339.8M and $89.5M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$80.89m
EquityUS$250.25m
Total liabilitiesUS$89.54m
Total assetsUS$339.79m

Recent financial health updates

Recent updates

Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%

Mar 22
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%

Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Jan 28
Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%

We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate

Jan 06
We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate

Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%

Nov 10
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%

These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat

Aug 14
These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat

Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?

Jul 12
Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?

Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)

May 15
Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)

Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%

Mar 21
Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%

We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully

Mar 12
We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully

Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price

Feb 13
Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price

Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%

Nov 18
Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%

Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation

Oct 30
Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation

Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test

Oct 04

Cue Health appoints chief medical oficer

Sep 08

Cue Health COVID-19 at-home, test-to-treat service launches nationwide

Aug 29

Cue Health Non-GAAP EPS of -$0.37 beats by $0.09, revenue of $87.7M beats by $34.8M

Aug 10

Cue Health's (NASDAQ:HLTH) Solid Profits Have Weak Fundamentals

May 18
Cue Health's (NASDAQ:HLTH) Solid Profits Have Weak Fundamentals

Financial Position Analysis

Short Term Liabilities: HLTH's short term assets ($110.4M) exceed its short term liabilities ($43.5M).

Long Term Liabilities: HLTH's short term assets ($110.4M) exceed its long term liabilities ($46.1M).


Debt to Equity History and Analysis

Debt Level: HLTH is debt free.

Reducing Debt: HLTH had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: HLTH has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: HLTH has less than a year of cash runway if free cash flow continues to reduce at historical rates of 56.4% each year


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.